Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Khaparde

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Indian Journal of Tuberculosis|April 5, 2022
Interventions to respond to COVID 19 pandemic in Mumbai and way forwardSunil Khaparde, Khyati Aroskar, Radha Taralekar, et al.
Indian Journal of Sexually Transmitted Diseases and AIDS|July 1, 2026
National technical guidelines on sexually transmitted infections and reproductive tract infections (2024): Summary of updated recommendations from the National AIDS and STD Control Program in IndiaAbhishek Royal, Hansa Lala, Vishal Yadav, et al.
The Lancet. Infectious Diseases|August 29, 2016
The number of privately treated tuberculosis cases in India: an estimation from drug sales dataNimalan Arinaminpathy, Deepak Batra, Sunil Khaparde, et al.
Plos One|September 8, 2017
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysisSunil Khaparde, Neeraj Raizada, Sreenivas Achuthan Nair, et al.
Scientific Reports|March 9, 2019
Modelling the impact of effective private provider engagement on tuberculosis control in urban IndiaNimalan Arinaminpathy, Sarang Deo, Simrita Singh, et al.
BMC Infectious Diseases|June 21, 2019
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales dataNimalan Arinaminpathy, Deepak Batra, Nilesh Maheshwari, et al.
The Indian Journal of Medical Research|September 2, 2017
Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for IndiaSurendra K Sharma, H Ryan, Sunil Khaparde, et al.
Plos One|June 6, 2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in IndiaSarang Deo, Pankaj Jindal, Devesh Gupta, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 16, 2015
Estimating disease burden of maternal syphilis and associated adverse pregnancy outcomes in India, Nigeria, and Zambia in 2012Xiang-Sheng Chen, Sunil Khaparde, Turlapati L N Prasad, et al.
The Lancet. Global Health|March 25, 2019
Assessing tuberculosis control priorities in high-burden settings: a modelling approachJuan F Vesga, Timothy B Hallett, Michael J A Reid, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Indian Journal of Tuberculosis|April 5, 2022
Interventions to respond to COVID 19 pandemic in Mumbai and way forwardSunil Khaparde, Khyati Aroskar, Radha Taralekar, et al.
Indian Journal of Sexually Transmitted Diseases and AIDS|July 1, 2026
National technical guidelines on sexually transmitted infections and reproductive tract infections (2024): Summary of updated recommendations from the National AIDS and STD Control Program in IndiaAbhishek Royal, Hansa Lala, Vishal Yadav, et al.
The Lancet. Infectious Diseases|August 29, 2016
The number of privately treated tuberculosis cases in India: an estimation from drug sales dataNimalan Arinaminpathy, Deepak Batra, Sunil Khaparde, et al.
Plos One|September 8, 2017
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysisSunil Khaparde, Neeraj Raizada, Sreenivas Achuthan Nair, et al.
Scientific Reports|March 9, 2019
Modelling the impact of effective private provider engagement on tuberculosis control in urban IndiaNimalan Arinaminpathy, Sarang Deo, Simrita Singh, et al.
BMC Infectious Diseases|June 21, 2019
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales dataNimalan Arinaminpathy, Deepak Batra, Nilesh Maheshwari, et al.
The Indian Journal of Medical Research|September 2, 2017
Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for IndiaSurendra K Sharma, H Ryan, Sunil Khaparde, et al.
Plos One|June 6, 2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in IndiaSarang Deo, Pankaj Jindal, Devesh Gupta, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 16, 2015
Estimating disease burden of maternal syphilis and associated adverse pregnancy outcomes in India, Nigeria, and Zambia in 2012Xiang-Sheng Chen, Sunil Khaparde, Turlapati L N Prasad, et al.
The Lancet. Global Health|March 25, 2019
Assessing tuberculosis control priorities in high-burden settings: a modelling approachJuan F Vesga, Timothy B Hallett, Michael J A Reid, et al.
Pageof 2